ALNOV:EPA
Novacyt SA
0,42 €
arrow_downward
-0,24%(-0,00100) 1D
10 қар., 11:55:56 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALNOV...
Open
0,42 €
High
0,42 €
Low
0,42 €
Mkt. cap
30,54 млн
Avg. vol.
173,25 м.
Volume
17,34 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
Open
0,42 €
High
0,42 €
Low
0,42 €
Mkt. cap
30,54 млн
Avg. vol.
173,25 м.
Volume
17,34 мың
52-wk high
1,04 €
52-wk low
0,29 €
EPS
-0,38 €
Shares outstanding
72,59 млн
No. of employees
228
News stories
From web sources and news partners
The Motley Fool
·
25 минут бұрын
This Vanguard ETF Has Outperformed the S&P 500 and Nasdaq Composite
Morningstar
·
5 минут бұрын
An Unconstrained Low-Volatility ETF
Bloomberg.com
·
35 минут бұрын
Asian Stocks to Rally on US Tech Surge, Oil Slump: Markets Wrap
Investor's Business Daily
·
8 сағат бұрын
Dow Jones Soars 1,132 Points As Amazon, Tesla Rally But Nvidia Dives; CPI Inflation Report Next
Profile
Novacyt Group is an Anglo-French biotechnology group focused on clinical diagnostics, with offices in Camberley, Surrey, United Kingdom and Vélizy-Villacoublay, France. The company produces in vitro and molecular diagnostic tests, supplying assays and reagents worldwide. Its business units include Primerdesign, Microgen Bioproducts and Lab21 Healthcare.
In January 2020 the company announced that its molecular diagnostics division, Primerdesign, had launched a molecular test for the 2019 strain of SARSr-CoV. The test was approved as eligible for procurement under the World Health Organization's Emergency Use Listing process in April 2020, meaning that the test could be supplied by the United Nations and other procurement agencies supporting the COVID-19 response. In the same month Novacyt announced a collaboration with AstraZeneca, GlaxoSmithKline and the University of Cambridge to support the UK in its COVID-19 national screening programme at a new testing laboratory at the university's Anne McLaren laboratory. Wikipedia
About Novacyt SA
CEODavid Allmond
Employees228
Founded2006 ж. 03 шіл.
Headquarters-
SectorHealth Care
Industry-
Websitenovacyt.com